Please assess the completion status of the following clinical trial:

Trial Title: Radiofrequency Ablation Versus Stereotactic Radiotherapy in Colorectal Liver Metastases

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adenocarcinoma of the colon or rectum~* Liver metastases~* Inoperable (technical or medical)~* 1-4 metastases~* Maximum 40 mm in diameter~* Suitable for both therapies, RFA and SBRT~Exclusion Criteria:~* Uncontrolled extrahepatic disease and uncontrolled primary cancer~* Liver cirrhosis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Stereotactic body radiation therapy (Type: EXPERIMENTAL): Colorectal liver metastases treated by SBRT
- Radiofrequency ablation (Type: ACTIVE_COMPARATOR): Colorectal liver metastases treated by RFA

Based on this trial design, predict the completion outcome and termination type (if applicable).